Pharma Mar (PHMMF)

Last Closing Price: --

Return on Equity (Annual)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

Pharma Mar (PHMMF) had Return on Equity of 29.78% for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$250.48M
$84.84M
$13.87M
$236.61M
$181.79M
$68.69M
$-1.20M
$67.49M
$67.49M
$84.84M
$84.84M
$84.84M
$84.84M
$68.69M
$77.77M
17.43M
17.45M
$4.87
$4.87
Balance Sheet Financials
$320.66M
$64.93M
$126.34M
$446.99M
$106.21M
$40.22M
$55.86M
$162.07M
$284.92M
$280.91M
$284.92M
17.36M
Cash Flow Statement Financials
$60.11M
$-68.78M
$-41.32M
$71.55M
$20.16M
$-51.39M
$2.32M
$-15.78M
--
Fundamental Metrics & Ratios
3.02
--
--
0.12
0.18
94.46%
27.42%
27.42%
31.05%
26.94%
33.87%
$52.80M
--
--
--
0.56
0.23
5.62
64.97
Return on Equity
29.78%
30.20%
18.98%
26.09%
$16.41
$3.03
$3.44